Icelandic Salmon AS (ICE:ISLAX)
Iceland · Delayed Price · Currency is ISK 1,170.00
-10.00 (-0.85%)
At close: Jul 29, 2025
Blueprint Medicines Revenue
In the year 2024, Icelandic Salmon AS had annual revenue of 98.42M EUR, down -39.48%. Icelandic Salmon AS had revenue of 61.18M in the half year ending December 31, 2024, a decrease of -27.32%.
Revenue
98.42M EUR
Revenue Growth
-39.48%
P/S Ratio
2.58
Revenue / Employee
622.89K EUR
Employees
158
Market Cap
36.32B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 98.42M | -64.20M | -39.48% |
| Dec 31, 2023 | 162.62M | 6.36M | 4.07% |
| Dec 31, 2022 | 156.26M | 65.46M | 72.09% |
| Dec 31, 2021 | 90.81M | 28.96M | 46.84% |
| Dec 31, 2020 | 61.84M | -4.83M | -7.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sildarvinnslan Hf. | 43.04B |
| Hagar | 184.39B |
| Brim hf. | 56.53B |
| Ölgerðin Egill Skallagrímsson | 34.03B |
| Iceland Seafood International | 63.99B |